Bhumsuk Keam
机构: Department of Internal Medicine, Seoul National University Hospital
每年引用次数
引用次数
引用: 17,646
H-指数: 63
I10-指数 : 238
出版物: 522
A Case of Nuclear Protein in Testis Midline Carcinoma Arising From the Submandibular Gland Duct in a Pregnant Patient.
Younghoon Cho , Bhum Suk Keam , Kyeong Cheon Jung , Bo Hae Kim
Journal of Oral and Maxillofacial Surgery 75 ( 9) 2020 -2024
2
2017
The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis
Jin Ho Song , Hong-Gyun Wu , Bhum Suk Keam , Jeong Hun Hah
Cancer Research and Treatment 48 ( 3) 917 -927
12
2016
Recent trends of aggressiveness in chemotherapy near the end of Life
Bhum Suk Keam , Dong Wan Kim , Tae You Kim , Yung Jue Bang
대한내과학회 추계학술발표논문집 2005 ( 1) 164 -164
2005
Pharmacogenomic prediction of response in advanced gastric cancer patients receiving modified FOLFOX-6 as a first-Line palliative chemotherapy
Bhum Suk Keam , Sae Won Han , Hye Seon Ham , Se Hoon Lee
대한내과학회 추계학술발표논문집 2005 ( 1) 161 -161
2005
Phase 2 study of 5-fluorouracil and cisplatin for inoperable hepatocellular carcinoma
Bhum Suk Keam , Keun Wook Lee , Se Hoon Lee , Dong Wan Kim
대한내과학회 추계학술발표논문집 2005 ( 1) 453 -453
2005
Fludarabine-based nonablative conditioning showed favorable outcomes compared to ablative conditioning in allogeneic stem cell transplantation for patients with advanced hematologic malignancies
In Ho Kim , Bhum Suk Keam , Kyung Hun Lee , Byung Soo Kim
대한내과학회 추계학술발표논문집 2005 ( 1) 154 -154
2005
The Hemoglobin A1C for Predicting Progression to Diabetes in Korean Adults: The Korean Genome and Epidemiology Study (초)
Sun Ja Choi , Bhum Suk Keam
대한당뇨병학회 학술발표논문집 2009 ( 1) 185 -185
2009
2-hour Plasma Glucose and Predicting Progression to Diabetes in Korean Adults: The Korean Genome and Epidemiology Study (초)
Sun Ja Choi , Bhum Suk Keam
대한당뇨병학회 학술발표논문집 2009 ( 1) 186 -186
2009
The Epidermal Growth Factor Receptor Status in Anaplastic Thyroid Carcinom
Jung Min Kim , Geon Kook Lee , Myoung Chul Kook , So Yeon Park
대한내분비학회 학술대회 초록집 2007 89 -89
2007
Genome-wide Association Study Identified TIMP2 Genetic Variant with Susceptibility to Osteoarthritis
Bhum-Suk Keam , Joo-Yeon Hwang , Min-Jin Go , Jee-Yeon Heo
Genomics & Informatics 9 ( 3) 121 -126
1
2011
The decision-making process regarding life-sustaining treatment in four countries: Taiwan, Japan, the US, and the UK
Eun Kyung CHOI , Jinui HONG , Min Sun KIM , Bhumsuk KEAM
Korean Journal of Medical Ethics 20 ( 2) 131 -151
11
2017
각국의 연명의료 관련 결정 절차와 기구에 관한 고찰: 대만, 일본, 미국, 영국을 중심으로
Jinui HONG , MinSun KIM , Bhumsuk KEAM , Miso KIM
The Korean Society For Medical Ethics
2017
Effect of Age on the Efficacy and Safety of Cabozantinib compared to Placebo in Patients with radioiodine-refractory (RAIR) differentiated Thyroid Cancer (DTC) who progressed after VEGFR-directed Therapy: Subgroup Analysis of the Phase 3 COSMIC 311 Study
J Duque-Afonso , B Robinson , J KRAJEWSKA , CC LIN
Oncology Research and Treatment
2022
S-589 Comparison of of three-weekly versus weekly cisplatin in concurrent chemoradiation for LA-HNSCC
So Yeon Lee , Bhum-suk Keam , Ki-hyeong Lee , Eun-kee Song
대한내과학회 추계학술발표논문집 2016 ( 1) 344 -344
2016
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer.
Bhumsuk Keam , Soyeon Kim , Yong-Oon Ahn , Tae Min Kim
Anticancer Research 35 ( 1) 175 -182
24
2015
The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen
Jin Won Kim , Seock-Ah Im , Miso Kim , Yongjun Cha
Anticancer Research 32 ( 4) 1547 -1553
24
2012
The CD56bright CD62L+ NKG2A+ immature cell subset is dominantly expanded in human cytokine-induced memory-like NK cells
Bhumsuk Keam , Bhumsuk Keam , Tae Min Kim , Tae Min Kim
bioRxiv 405134
2018
Korean Version of the Patient Dignity Inventory: Translation and Validation in Patients With Advanced Cancer.
Bhumsuk Keam , Kangkook Lee , Young Ho Yun , Jae Yong Shim
Journal of Pain and Symptom Management
2021
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Bhumsuk Keam , Dae Seog Heo , Miso Kim , Tae Min Kim
Thoracic Cancer 12 ( 5) 619 -630
2021
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Bhumsuk Keam , Bhumsuk Keam , Dong-Wan Kim , Dong-Wan Kim
Cancer Research and Treatment
2021